JP2008525400A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008525400A5 JP2008525400A5 JP2007547628A JP2007547628A JP2008525400A5 JP 2008525400 A5 JP2008525400 A5 JP 2008525400A5 JP 2007547628 A JP2007547628 A JP 2007547628A JP 2007547628 A JP2007547628 A JP 2007547628A JP 2008525400 A5 JP2008525400 A5 JP 2008525400A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkoxy
- group
- halo
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 28
- 125000003545 alkoxy group Chemical group 0.000 claims 22
- 125000005843 halogen group Chemical group 0.000 claims 19
- 150000001875 compounds Chemical class 0.000 claims 14
- 229910052736 halogen Inorganic materials 0.000 claims 9
- 150000002367 halogens Chemical class 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 229910052799 carbon Inorganic materials 0.000 claims 6
- 150000002431 hydrogen Chemical class 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 125000001054 5 membered carbocyclic group Chemical group 0.000 claims 5
- 125000004414 alkyl thio group Chemical group 0.000 claims 5
- 239000005557 antagonist Substances 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 208000035475 disorder Diseases 0.000 claims 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 4
- 125000004008 6 membered carbocyclic group Chemical group 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 125000005059 halophenyl group Chemical group 0.000 claims 4
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000012453 solvate Substances 0.000 claims 4
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 3
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 3
- 206010012289 Dementia Diseases 0.000 claims 3
- 208000028017 Psychotic disease Diseases 0.000 claims 3
- 102100023145 Sodium- and chloride-dependent glycine transporter 1 Human genes 0.000 claims 3
- 101710083171 Sodium- and chloride-dependent glycine transporter 1 Proteins 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims 3
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 claims 3
- 230000001404 mediated effect Effects 0.000 claims 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 201000000980 schizophrenia Diseases 0.000 claims 3
- 125000006555 (C3-C5) cycloalkyl group Chemical group 0.000 claims 2
- 125000001845 4 membered carbocyclic group Chemical group 0.000 claims 2
- 125000001960 7 membered carbocyclic group Chemical group 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 239000000556 agonist Substances 0.000 claims 2
- 239000000935 antidepressant agent Substances 0.000 claims 2
- 229940005513 antidepressants Drugs 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 239000012896 selective serotonin reuptake inhibitor Substances 0.000 claims 2
- 229940124834 selective serotonin reuptake inhibitor Drugs 0.000 claims 2
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 1
- RGHPCLZJAFCTIK-UHFFFAOYSA-N 2-methylpyrrolidine Chemical group CC1CCCN1 RGHPCLZJAFCTIK-UHFFFAOYSA-N 0.000 claims 1
- 101000783611 Takifugu rubripes 5-hydroxytryptamine receptor 1D Proteins 0.000 claims 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 claims 1
- 125000005332 alkyl sulfoxy group Chemical group 0.000 claims 1
- 230000001430 anti-depressive effect Effects 0.000 claims 1
- 229940125681 anticonvulsant agent Drugs 0.000 claims 1
- 239000001961 anticonvulsive agent Substances 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 239000003693 atypical antipsychotic agent Substances 0.000 claims 1
- 229940127236 atypical antipsychotics Drugs 0.000 claims 1
- -1 chloro, bromo, iodo, hydroxy Chemical group 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 230000003291 dopaminomimetic effect Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000002664 nootropic agent Substances 0.000 claims 1
- 230000001777 nootropic effect Effects 0.000 claims 1
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 claims 1
- 239000003775 serotonin noradrenalin reuptake inhibitor Substances 0.000 claims 1
- 239000000952 serotonin receptor agonist Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 claims 1
- AAZSFEOLTIPTFQ-UHFFFAOYSA-N CC(c(c(N)c(c(N)c1N)N)c1N)=O Chemical compound CC(c(c(N)c(c(N)c1N)N)c1N)=O AAZSFEOLTIPTFQ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0428231A GB0428231D0 (en) | 2004-12-23 | 2004-12-23 | Compounds |
| GB0509204A GB0509204D0 (en) | 2005-05-05 | 2005-05-05 | Compounds |
| GB0524320A GB0524320D0 (en) | 2005-11-29 | 2005-11-29 | Compounds |
| PCT/GB2005/004951 WO2006067423A1 (en) | 2004-12-23 | 2005-12-21 | Glycine transport inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008525400A JP2008525400A (ja) | 2008-07-17 |
| JP2008525400A5 true JP2008525400A5 (enExample) | 2008-12-25 |
Family
ID=36051583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007547628A Withdrawn JP2008525400A (ja) | 2004-12-23 | 2005-12-21 | グリシン輸送阻害剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7745642B2 (enExample) |
| EP (1) | EP1841727A1 (enExample) |
| JP (1) | JP2008525400A (enExample) |
| KR (1) | KR20070091210A (enExample) |
| AR (1) | AR055296A1 (enExample) |
| AU (1) | AU2005317950A1 (enExample) |
| BR (1) | BRPI0519366A2 (enExample) |
| CA (1) | CA2592467A1 (enExample) |
| EA (1) | EA011638B1 (enExample) |
| IL (1) | IL183975A0 (enExample) |
| MA (1) | MA29099B1 (enExample) |
| MX (1) | MX2007007888A (enExample) |
| NO (1) | NO20073300L (enExample) |
| PE (1) | PE20061156A1 (enExample) |
| TW (1) | TW200633957A (enExample) |
| WO (1) | WO2006067423A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20061330A1 (es) * | 2004-12-23 | 2006-12-27 | Glaxo Group Ltd | Compuestos derivados de benzamida como inhibidores del transportador de glicina |
| WO2006067414A2 (en) * | 2004-12-23 | 2006-06-29 | Glaxo Group Limited | Glycine transport inhibitors |
| PE20061156A1 (es) | 2004-12-23 | 2006-12-16 | Glaxo Group Ltd | Derivados de benzamida como agentes inhibidores del transportador de glicina |
| GB0428233D0 (en) * | 2004-12-23 | 2005-01-26 | Glaxo Group Ltd | Compounds |
| GB0600427D0 (en) | 2006-01-10 | 2006-02-15 | Glaxo Group Ltd | Compounds |
| GB0612435D0 (en) * | 2006-06-22 | 2006-08-02 | Glaxo Group Ltd | Compounds |
| GB0612437D0 (en) * | 2006-06-22 | 2006-08-02 | Glaxo Group Ltd | Compounds |
| GB0612416D0 (en) * | 2006-06-22 | 2006-08-02 | Glaxo Group Ltd | Compounds |
| GB0612425D0 (en) * | 2006-06-22 | 2006-08-02 | Glaxo Group Ltd | Compounds |
| GB0612420D0 (en) * | 2006-06-22 | 2006-08-02 | Glaxo Group Ltd | Compounds |
| WO2008155334A2 (en) * | 2007-06-20 | 2008-12-24 | Glaxo Group Limited | Improved process of amide formation |
| US8080541B2 (en) * | 2009-08-27 | 2011-12-20 | Hoffman-La Roche Inc. | Carbocyclic GlyT-1 receptor antagonists |
| US8524909B2 (en) * | 2010-02-02 | 2013-09-03 | Hoffmann-La Roche Inc. | Tetrahydro-pyran derivatives |
| EP2575815A4 (en) | 2010-06-04 | 2013-12-25 | Albany Molecular Res Inc | GLYCIN TRANSPORTER 1 INHIBITORS, METHODS OF MAKING THE SAME, AND USES THEREOF |
| EP2763676B1 (en) | 2011-10-03 | 2019-12-25 | The University of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
| TW201427947A (zh) | 2012-10-12 | 2014-07-16 | Lundbeck & Co As H | 環狀胺 |
| WO2022051804A1 (en) * | 2020-09-08 | 2022-03-17 | The University Of Western Australia | Compounds and methods |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2746959A (en) | 1953-06-02 | 1956-05-22 | American Home Prod | Diphenylethylenediamine-penicillin salt |
| US3145209A (en) | 1961-07-31 | 1964-08-18 | Olin Mathieson | Substituted aminophenyl-ethylamine derivatives |
| BE789025A (fr) | 1971-09-23 | 1973-03-20 | Allen & Hanburys Ltd | Nouvelles ethylene diamines substituees |
| NZ237443A (en) | 1990-04-10 | 1993-11-25 | Asta Medica Ag | Phenalkylethylenediamine and aminomethyltetra hydroisoquinoline derivatives, platinum (ii) and (iv) complexes, methods of preparation and pharmaceutical compositions |
| CA2322164A1 (en) | 1998-03-06 | 1999-09-10 | Ludo Edmond Josephine Kennis | Glycine transport inhibitors |
| EP1296950A2 (en) | 2000-04-20 | 2003-04-02 | NPS Allelix Corp. | Aminopiperidines for use as glyt-1 inhibitors |
| DE60229646D1 (de) | 2001-07-17 | 2008-12-11 | Organon Nv | N- (1-dimethylaminocycloalkyl)methyl benzamid-derivate |
| GB0130696D0 (en) * | 2001-12-21 | 2002-02-06 | Smithkline Beecham Plc | Chemical Compounds |
| BRPI0407543A (pt) | 2003-02-17 | 2006-02-14 | Hoffmann La Roche | derivados de piperidina-benzenossulfonamida |
| ATE410161T1 (de) | 2003-05-02 | 2008-10-15 | Elan Pharm Inc | 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazol-3- carbonsäureamid-derivate und verwandte verbindungen als bradykinin b1 rezeptor antagonisten zur behandlung von entzündlichen erkrankungen |
| DK1663232T3 (da) | 2003-09-09 | 2008-02-04 | Hoffmann La Roche | Benzimidazolderivater som human chymase-inhibitorer |
| FR2861073B1 (fr) | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| FR2861070B1 (fr) | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique |
| FR2861071B1 (fr) | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique |
| EP1593671A1 (en) | 2004-03-05 | 2005-11-09 | Graffinity Pharmaceuticals AG | DPP-IV inhibitors |
| GB0408777D0 (en) | 2004-04-20 | 2004-05-26 | Glaxo Group Ltd | Compounds |
| EP1745018A1 (en) | 2004-04-29 | 2007-01-24 | Merck & Co., Inc. | Azetidine glycine transporter inhibitors |
| WO2006067414A2 (en) | 2004-12-23 | 2006-06-29 | Glaxo Group Limited | Glycine transport inhibitors |
| PE20061156A1 (es) | 2004-12-23 | 2006-12-16 | Glaxo Group Ltd | Derivados de benzamida como agentes inhibidores del transportador de glicina |
| PE20061330A1 (es) | 2004-12-23 | 2006-12-27 | Glaxo Group Ltd | Compuestos derivados de benzamida como inhibidores del transportador de glicina |
| GB0612420D0 (en) | 2006-06-22 | 2006-08-02 | Glaxo Group Ltd | Compounds |
-
2005
- 2005-12-16 PE PE2005001492A patent/PE20061156A1/es not_active Application Discontinuation
- 2005-12-21 EA EA200701356A patent/EA011638B1/ru not_active IP Right Cessation
- 2005-12-21 MX MX2007007888A patent/MX2007007888A/es active IP Right Grant
- 2005-12-21 TW TW094145554A patent/TW200633957A/zh unknown
- 2005-12-21 AR ARP050105435A patent/AR055296A1/es not_active Application Discontinuation
- 2005-12-21 AU AU2005317950A patent/AU2005317950A1/en not_active Abandoned
- 2005-12-21 WO PCT/GB2005/004951 patent/WO2006067423A1/en not_active Ceased
- 2005-12-21 US US11/718,333 patent/US7745642B2/en not_active Expired - Fee Related
- 2005-12-21 BR BRPI0519366-4A patent/BRPI0519366A2/pt not_active IP Right Cessation
- 2005-12-21 KR KR1020077016780A patent/KR20070091210A/ko not_active Withdrawn
- 2005-12-21 EP EP05820463A patent/EP1841727A1/en not_active Withdrawn
- 2005-12-21 JP JP2007547628A patent/JP2008525400A/ja not_active Withdrawn
- 2005-12-21 CA CA002592467A patent/CA2592467A1/en not_active Abandoned
-
2007
- 2007-06-14 IL IL183975A patent/IL183975A0/en unknown
- 2007-06-18 MA MA30002A patent/MA29099B1/fr unknown
- 2007-06-27 NO NO20073300A patent/NO20073300L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008525400A5 (enExample) | ||
| JP2013509392A5 (enExample) | ||
| MX2015015893A (es) | 2-fenilimidazo[1,2-a]pirimidinas como agentes formadores de imagen. | |
| JP2007528883A5 (enExample) | ||
| JP2015143283A5 (enExample) | ||
| JP2006524222A5 (enExample) | ||
| BR122017003181A2 (pt) | composto inibidor de trk, composição farmacêutica e medicamento compreendendo dito composto e seu uso para profilaxia e/ou terapia de doença relacionada à trk e/ou para inibir trk | |
| JP2010504286A5 (enExample) | ||
| DE60311821D1 (de) | Dibenzylaminverbindung und deren medizinische verwendung | |
| CO6150176A2 (es) | Derivados de bencimidazol utiles en el tratamiento de los trastornos relacionados con el receptor vaniloide trpv1 | |
| NZ601967A (en) | Pde10 inhibitors and related compositions and methods | |
| JP2005518414A5 (enExample) | ||
| JP2013542213A5 (enExample) | ||
| JP2010527983A5 (enExample) | ||
| JP2016540742A5 (enExample) | ||
| JP2010524899A5 (enExample) | ||
| JP2013505948A5 (enExample) | ||
| RU2011102396A (ru) | Аминосоединения и их медицинское применение | |
| JP2010155827A5 (enExample) | ||
| JP2010535790A5 (enExample) | ||
| CN111601797A (zh) | 苯并哌啶或杂芳基并哌啶类衍生物、其制备方法及其在医药上的应用 | |
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| JP2012507525A5 (enExample) | ||
| NO20055655D0 (no) | Anvendelse av azetidinkarboksamidderivater i terapi | |
| JPWO2021107065A5 (enExample) |